Yahoo Canada Web Search

Search results

      • It was first passed in 1920 and most recently revised in 1985. It attempts to ensure that these products are safe, that their ingredients are disclosed and that drugs are effective and are not sold as food or cosmetics.
      en.wikipedia.org/wiki/Food_and_Drugs_Act
  1. People also ask

  2. Health Canada is responsible for establishing standards for the safety and nutritional quality of all foods sold in Canada. The department exercises this mandate under the authority of the Food and Drugs Act and pursue its regulatory mandate under the Food and Drug Regulations.

  3. An Act to amend the Food and Drugs Act, the Hazardous Products Act, the Radiation Emitting Devices Act, the Canadian Environmental Protection Act, 1999, the Pest Control Products Act and the Canada Consumer Product Safety Act and to make related amendments to another Act (Bill C, assented to 2016-12-12)

  4. The Food and Drugs Act (and the Food and Drug Regulations), will continue to apply to all food sold in Canada. The SFCA and the SFCR mainly apply to food that is imported, exported and traded inter-provincially.

  5. Dec 6, 2013 · 2013-12-06. Outlines Health Canada's legal role regarding drugs and health products with links to related acts, regulations, guidelines and policies.

  6. laws.justice.gc.ca › eng › actsFood and Drugs Act

    Table of Contents. Food and Drugs Act. 1 - Short Title. 2 - Interpretation and Application. 3 - PART I - Foods, Drugs, Cosmetics and Devices. 3 - General. 4 - Food. 8 - Drugs. 16 - Cosmetics.

  7. The Food and Drugs Act (French: Loi sur les aliments et drogues) is an act of the Parliament of Canada regarding the production, import, export, transport across provinces and sale of food, drugs, contraceptive devices and cosmetics (including personal cleaning products such as soap and toothpaste). It was first passed in 1920 and most recently ...

  8. Scope and Application. The amendments to the Food and Drugs Act, which only apply to therapeutic products, give the Minister of Health an improved ability to identify, assess and take action when a therapeutic product presents a serious risk to the public.